Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
Autoři | |
---|---|
Rok publikování | 2023 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Annals of hematology |
Fakulta / Pracoviště MU | |
Citace | |
www | https://link.springer.com/article/10.1007/s00277-023-05479-w |
Doi | http://dx.doi.org/10.1007/s00277-023-05479-w |
Klíčová slova | Acute and chronic GVHD; AlloHSCT; ATG Grafalon |
Přiložené soubory | |
Popis | Since 2006, combined graft-versus-host disease (GVHD) prophylaxis with ATG Grafalon has been our department's base of peri-transplant supportive care. This recent retrospective study included 398 patients who underwent their first allogeneic hematopoietic stem cell transplantation after receiving a defined dose of ATG Grafalon. Our observations recorded reduced incidence of severe acute and chronic GVHD without negative impact on overall survival in a nonselected group with standard and uniform GVHD prophylaxis. |
Související projekty: |